Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
3.800
-0.110 (-2.82%)
Streaming Delayed Price
Updated: 12:40 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
September 18, 2023
From
Enveric Biosciences
Via
Business Wire
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
↗
September 11, 2023
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification
Via
Benzinga
Topics
Artificial Intelligence
Enveric Biosciences Files Provisional Patent Application for AI-based Computational Methods for Identifying and Optimizing Novel Tryptamine Derivatives
September 11, 2023
From
Enveric Biosciences
Via
Business Wire
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
↗
September 05, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Via
Benzinga
Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives
September 05, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Present at H.C. Wainwright 25th Annual Global Conference
August 30, 2023
From
Enveric Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 29, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
August 29, 2023
It's time for another dive into the biggest pre-market stock movers as we check out the shares worth watching on Tuesday!
Via
InvestorPlace
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
↗
August 28, 2023
The USPTO issued a patent covering Enveric Biosciences’ (NASDAQ: ENVB) lead candidate EB-373, a psilocin prodrug under development for the treatment of anxiety disorder.
Via
Benzinga
Topics
Intellectual Property
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
↗
August 28, 2023
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Via
Benzinga
Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs
August 28, 2023
From
Enveric Biosciences
Via
Business Wire
Cannabis Stock Gainers And Losers From August 24, 2023
↗
August 24, 2023
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For August 23, 2023
↗
August 23, 2023
Via
Benzinga
Topics
Cannabis
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
↗
August 21, 2023
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
Via
Benzinga
Topics
Cannabis
Economy
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
↗
August 21, 2023
Enveric Biosciences (NASDAQ: ENVB) has completed manufacturing of drug material enabling the completion of preclinical work for EB-373 including all bioanalytical method validation, GLP toxicology and...
Via
Benzinga
Marijuana Stock Movers For August 22, 2023
↗
August 22, 2023
Via
Benzinga
Topics
Cannabis
Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program
August 21, 2023
From
Enveric Biosciences
Via
Business Wire
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
↗
August 21, 2023
Via
Benzinga
Topics
Cannabis
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
↗
August 14, 2023
Next-gen psychedelics business Enveric Biosciences (NASDAQ: ENVB) reported its unaudited financial results for the second quarter of 2023 ended June 30. Results show:
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
↗
August 16, 2023
Via
Benzinga
Topics
Cannabis
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
↗
August 14, 2023
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published
Via
Benzinga
Marijuana Stock Movers For August 15, 2023
↗
August 15, 2023
Via
Benzinga
Topics
Cannabis
Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results
August 14, 2023
From
Enveric Biosciences, Inc.
Via
Business Wire
Cannabis Stock Gainers And Losers From August 11, 2023
↗
August 11, 2023
Via
Benzinga
Topics
Cannabis
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 08, 2023
Via
Benzinga
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
↗
August 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 07, 2023
Via
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
↗
August 03, 2023
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...
Via
Benzinga
Cannabis Stock Movers For August 3, 2023
↗
August 03, 2023
Via
Benzinga
Marijuana Stock Movers For July 31, 2023
↗
July 31, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
